HF Patho Flashcards
1
Q
Heart Failure Definition
A
- Signs and symptoms of intravascular and interstitial volume overload resulting in symptoms of SOB and/or edema
- Manifestations of inadequate tissue perfusion resulting in symptoms of fatigue and/or poor exercise tolerance
2
Q
Cardiac Output
A
HR * SV
- Normal: 5-8 L/min
- SV = EDV - ESV
- HR: depends on SNS and PNS
- SV: depends on preload, afterload, and contractility
3
Q
Preload
A
- Left ventricular end-diastolic pressure (LVEDP)
- Measured as pulmonary capillary wedge pressure (PCWP)
4
Q
Afterload
A
-Systemic vascular resistance (SVR)
5
Q
Contractility
A
- Ability of contractile elements to interact and shorten against a load
- (+)/(-) inotropy
6
Q
Blood Pressure
A
CO * TPR
7
Q
LVEF
A
- Left ventricular ejection fraction
- SV/EDV
- Normal: 50-70%
- Requires objective measure of systolic function (ECHO, RNV, cardiac catheterization)
8
Q
Angiotensin II Elevation in HF
A
- Myocyte hypertrophy => remodeling, myocardial dysfunction
- Increased PAI-I levels => thrombosis
- Increased proximal Na+ reabsorption => Increased ECF volume, pulmonary/peripheral edema
- Increased thirst => dilutional hyponatremia
- Increased pituitary AVP release => vasoconstriction, water retention
- Increased pre-synaptic NE release => tachycardia, arrhythmia, myocyte toxicity
- Renal efferent arteriole vasoconstriction => decreased renal blood flow
- Increased adrenal aldosterone release =>increased distal tubular Na+ reabsorption, myocardial fibrosis
- Vascular smooth muscle contraction => increased cardiac afterload
- Vascular smooth muscle hypertrophy: decreased vascular compliance, atherosclerosis
9
Q
Hemodynamic Effects of Aldosterone in HF
A
- Retention of Na+ and water
- Increased plasma fluid volume
- Elevated BP
10
Q
Non-Hemodynamic Effects of Aldosterone in HF
A
- Myocardial and vascular fibrosis
- Impaired arterial compliance
- Baroreceptor dysfunction
- Sympathetic activation
- Excretion of K+ and Mg++
- Elevated ANP
- Parasympathetic inhibition
11
Q
SNS Activation in HF
A
- Increased HR: arrhythmias, impaired diastolic filling, increased myocardial energy demand
- Vasoconstriction: increased afterload
- Increased plasma renin activity: increased preload
- Direct toxic effects of NE: Apoptosis
- Desensitization to catecholamines
- Myocardial remodeling
12
Q
Vasopressin (AVP)
A
- Antidiuretic hormone (ADH)
- Regulates extracellular fluid volume by affecting renal handling of water
- AVP acts on renal collecting duct via V2 receptor to promote free water absorption
- Results in increased BV, CO, and arterial pressure
- AVP also acts on V1a receptors on vascular smooth muscle promoting vasoconstriction
13
Q
BNP
A
- One of four human natriuretic peptides (ANP, BNP, CNP, and DNP)
- Released from ventricles in response to ventricular stretching from volume overload
- Promotes diuresis, natriuresis, and vasodilation
- Metabolized by neutral endopeptidase
- Used diagnostically to rule out HF and potentially can be used to guide therapy